NCT04945135 is a clinical trial in Liver Transplant, sponsored by Hospital Clinic of Barcelona.

Who is sponsoring NCT04945135?

NCT04945135 is sponsored by Hospital Clinic of Barcelona.

What condition does NCT04945135 study?

NCT04945135 studies Liver Transplant.

Is NCT04945135 still recruiting?

NCT04945135 is currently completed. Last updated 30 June 2021.

Last reviewed 2021-06-30 · How we verify

NCT04945135

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Controlled Donors After Circulatory Death and Brain Death: a Multicenter Study of Transfusion, One-year Graft Survival and Mortality. Cohort Study,

Completed Last updated 30 June 2021

What this trial tests

trial in Liver Transplant in 591 participants. Completed in 25 June 2021.

Timeline

1 June 2019

Primary endpoint
1 January 2020

25 June 2021

Quick facts

Lead sponsor	Hospital Clinic of Barcelona
Status	Completed
Study type	OBSERVATIONAL
Enrollment	591
Start date	1 June 2019
Primary completion	1 January 2020
Estimated completion	25 June 2021
Sites	2 locations across Spain

Conditions studied

Liver Transplant — all drugs for Liver Transplant →

Sponsor

Hospital Clinic of Barcelona

Who can join

18 and older, any sex, with Liver Transplant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

RBC requirement ein DBD and DCD liver transplants

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Liver Transplant

Currently open trials in the same condition.

NCT06254248 — Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma · Phase 2 · recruiting
NCT06832189 — EVR and EPO for Liver Transplant Tolerance · Phase 1 · recruiting
NCT07216508 — Liver Transplant CGM · recruiting
NCT07086989 — Cardiovascular Risk in Children With Chronic Conditions Study · recruiting
NCT06813508 — Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH · recruiting

Other Hospital Clinic of Barcelona trials

Trials by the same sponsor.

NCT07509814 — Extended Versus Short Prehabilitation Programme for Patients With Advanced Ovarian Cancer Undergoing Major Surgery · NA · not yet recruiting
NCT07469358 — iCBT for Adolescents Obsessive-compulsive Dissorder · NA · active not recruiting
NCT07358611 — Non-invasive Mapping-Guided Atrial Fibrillation Ablation · NA · recruiting
NCT07237867 — Frequency-Dependent Effects of Percutaneous Femoral Nerve Stimulation on Quadriceps Strength in Athletes With Patellar T · NA · recruiting
NCT07163936 — Analysis of the Influence of Dialysis Fluid Composition on Vascular Calcification in Patients With Chronic Kidney Diseas · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04945135 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Clinic of Barcelona
Last refreshed: 30 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04945135.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing